Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by JDavenport


V.BTI.H

It's snowing, hard!

Bioasis has just posted 16 material change and material contracts documents...

December 20, 2022

V.BTI.H

Off to Boomskid

I think they, Dr. Deborah Rathjen and Ladenburg Thalmann, have won. It's...

December 17, 2022

V.BTI.H

RE:JBroke out I’m in!

Pretty easy decision, MT, to buy Bioasis at 6¢. Ladenburg Thalmann...

December 17, 2022

V.BTI.H

And...

Don't forget that Biodexa will be 75% owned by Lind, Ladenburg Thalmann...

December 16, 2022

V.BTI.H

RE:RE:RE:The SMOKING Gun!!!

So, poof, if they're getting out of the platform delivery business, are...

December 16, 2022

V.BTI.H

RE:RE:The SMOKING Gun!!!

That's a description of xB3 therapeutics, KBC, and Biodexa unquestionably...

December 16, 2022

V.BTI.H

RE:Bottom Line: xB3 never in a stronger position

poof, Biodexa has stated that they will not retain control of the xB3...

December 16, 2022

V.BTI.H

RE:A Different Deal

And if the deal takes more than 4 sheets of toilet paper to write out, it'...

December 16, 2022

V.BTI.H

A Different Deal

Tell Deborah that you want a different deal. SInce they're going to sell...

December 16, 2022

V.BTI.H

Craig!

Up now to 20 shareholders contacting me. How you doing? I'm tired...

December 16, 2022

V.BTI.H

Vision! What...!

I just chatted with one of my buddies who attended a roadshow. He said that...

December 16, 2022

V.BTI.H

RE:Volume

To the "Volume" post we might add that the closing price of BTI was...

December 16, 2022

V.BTI.H

RE:RE:The SMOKING Gun!!!

Are you being paid or are you receiving any benefits from anybody to promote...

December 16, 2022

V.BTI.H

RE:RE:The SMOKING Gun!!!

I wonder what other gems are in the filings.Do you need to know anything more...

December 16, 2022

V.BTI.H

RE:The SMOKING Gun!!!

When they sell the xB3 platform to DrDR's Medicine Show, they will point...

December 16, 2022

V.BTI.H

The SMOKING Gun!!!

It's my turn to do a little copy/pasting. Here is Midatech stating its...

December 16, 2022

V.BTI.H

RE:RE:RE:Glioblastoma market US$4.2 billion in 2028

In the next 4 to 5 years, poof. And the minute that Biodexa publicly...

December 16, 2022

V.BTI.H

RE:RE:RE:Glioblastoma market US$4.2 billion in 2028

Bwah hahaha. Gobbledeegook, poof, copied, pasted, and undigested. And yet...

December 16, 2022

V.BTI.H

RE:Glioblastoma market US$4.2 billion in 2028

It will be years before xB3 versions of Midatech's drugs can be designed,...

December 16, 2022

V.BTI.H

RE:RE:RE:RE:RE:RE:panobinostat, lomustine, xB3-bevacizumab

Yes, craig, I mean, no, craig, the documents do not lie. I take them...

December 16, 2022

Featured Company